Association of Cardiovascular Health Metrics and Mortality Among Individuals With and Without Cancer.


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
05 Mar 2024
Historique:
medline: 11 3 2024
pubmed: 23 2 2024
entrez: 23 2 2024
Statut: ppublish

Résumé

Although metrics of cardiovascular health have been associated with improved mortality, whether the association remains among individuals with a history of cancer has not been well characterized. The National Health and Nutrition Examination Survey data from 2009 to 2018 were used to identify individuals with and without a history of cancer. For each participant, American Heart Association Life's Essential 8 cardiovascular health metrics of health behaviors (diet, physical activity, nicotine exposure, and sleep) and health factors (body mass index, non-high-density lipoprotein cholesterol, blood glucose, and blood pressure) were obtained. All-cause, cardiovascular, and cancer-related mortality were noted. Out of 21 967 individuals, 8% had a history of cancer. In analyses adjusted for age, race and ethnicity, sex, and income among the whole cohort, better Life's Essential 8 cardiovascular health metrics were associated with lower all-cause (adjusted hazard ratio [aHR ], 0.38 [95% CI, 0.29-0.49]; Better metrics of cardiovascular health, particularly health behaviors, are associated with improved all-cause, cardiovascular, and cancer mortality to a similar extent in individuals with and without cancer. Attempts to improve cardiovascular health should be prioritized similarly among individuals with and without cancer.

Sections du résumé

BACKGROUND BACKGROUND
Although metrics of cardiovascular health have been associated with improved mortality, whether the association remains among individuals with a history of cancer has not been well characterized.
METHODS AND RESULTS RESULTS
The National Health and Nutrition Examination Survey data from 2009 to 2018 were used to identify individuals with and without a history of cancer. For each participant, American Heart Association Life's Essential 8 cardiovascular health metrics of health behaviors (diet, physical activity, nicotine exposure, and sleep) and health factors (body mass index, non-high-density lipoprotein cholesterol, blood glucose, and blood pressure) were obtained. All-cause, cardiovascular, and cancer-related mortality were noted. Out of 21 967 individuals, 8% had a history of cancer. In analyses adjusted for age, race and ethnicity, sex, and income among the whole cohort, better Life's Essential 8 cardiovascular health metrics were associated with lower all-cause (adjusted hazard ratio [aHR ], 0.38 [95% CI, 0.29-0.49];
CONCLUSIONS CONCLUSIONS
Better metrics of cardiovascular health, particularly health behaviors, are associated with improved all-cause, cardiovascular, and cancer mortality to a similar extent in individuals with and without cancer. Attempts to improve cardiovascular health should be prioritized similarly among individuals with and without cancer.

Identifiants

pubmed: 38390816
doi: 10.1161/JAHA.123.032683
pmc: PMC10944047
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e032683

Références

Lancet. 2019 Sep 21;394(10203):986-988
pubmed: 31443925
J Am Heart Assoc. 2017 Mar 20;6(3):
pubmed: 28320747
J Cancer Surviv. 2024 Feb;18(1):124-134
pubmed: 37140677
Circulation. 2023 Apr 11;147(15):1137-1146
pubmed: 37036905
J Clin Med. 2022 Dec 08;11(24):
pubmed: 36555905
Cancers (Basel). 2022 Apr 16;14(8):
pubmed: 35454932
Curr Oncol. 2017 Oct;24(5):e348-e353
pubmed: 29089804
Circulation. 2022 Sep 13;146(11):822-835
pubmed: 35766033
J Am Heart Assoc. 2023 Dec 5;12(23):e030942
pubmed: 38038218
Eur Heart J. 2015 May 14;36(19):1157-62
pubmed: 25776859
Nutr J. 2020 Apr 22;19(1):37
pubmed: 32321528
Am J Lifestyle Med. 2016 Aug 04;12(3):184-199
pubmed: 30202391
Vital Health Stat 2. 2013 Sep;(161):1-24
pubmed: 25090154
J Cancer Surviv. 2013 Jun;7(2):253-61
pubmed: 23417882
Circulation. 2013 Mar 26;127(12):1270-5
pubmed: 23509058
Eur Heart J Qual Care Clin Outcomes. 2022 Oct 26;8(7):787-797
pubmed: 35913736
Lancet Oncol. 2017 Aug;18(8):e457-e471
pubmed: 28759385
Circulation. 2018 Aug 14;138(7):735-742
pubmed: 30359132

Auteurs

Dmitry Abramov (D)

Division of Cardiology, Department of Medicine Loma Linda University Health Loma Linda CA USA.

Ofer Kobo (O)

Department of Cardiology Hillel Yaffe Medical Center Hadera Israel.
Keele Cardiovascular Research Group, Centre for Prognosis Research Keele University Stoke-on-Trent United Kingdom.

Mamas A Mamas (MA)

Keele Cardiovascular Research Group, Centre for Prognosis Research Keele University Stoke-on-Trent United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH